Picking embryos with best health odds sparks new DNA debate

A handful of companies in the US and Europe are offering embryo risk scores for conditions including schizophrenia, breast cancer and diabetes.
New: Gift this subscriber-only story to your friends and family

BOSTON (BLOOMBERG) - Dr Rafal Smigrodzki will not make a big deal of it, but someday, when his toddler daughter Aurea is old enough to understand, he plans to explain that she likely made medical history at the moment of her birth.

Aurea appears to be the first child born after a new type of DNA testing that gave her a "polygenic risk score". It is based on multiple common gene variations that could each have tiny effects. Together, they create higher or lower odds for many common diseases.

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and straitstimes.com

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Join ST's Telegram channel and get the latest breaking news delivered to you.